Physician

Bijal J Modi, M.D.

According to 2025 Medicare claims, Bijal Modi, M.D. (NPI: 1285684944) practices internal medicine in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Dallas, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1003083445; TIN: 752131429) and primary practice location at 75231-7001. Modi is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Modi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 654 traditional Medicare patients, billed 108,832 HCPCS/CPT codes, and received $1,825,619 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,305 prescription claims across 185 beneficiaries totaling $2,786,527 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 75 claims. Open Payments data shows 18 records totaling $409. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,369,935 to $1,825,619. Similarly, Part D prescription costs have risen steadily, from $433,916 to $2,786,527. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	380	122,043	$1,369,935
2016	550	137,365	$1,723,287
2017	673	113,885	$1,691,292
2018	657	127,639	$2,000,835
2019	725	161,836	$2,094,727
2020	688	146,372	$1,950,011
2021	705	155,609	$2,306,131
2022	755	148,741	$2,445,874
2023	708	126,543	$2,058,071
2024	654	108,832	$1,825,619

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	155	946	$433,916
2016	181	1,481	$1,053,835
2017	165	1,396	$1,717,473
2018	174	1,299	$2,056,656
2019	185	1,347	$2,328,223
2020	184	1,473	$2,483,157
2021	188	1,293	$2,256,469
2022	197	1,300	$2,705,432
2023	214	1,407	$2,916,489
2024	185	1,305	$2,786,527

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	106	$13,344
2016	N/R	141	$33,431
2017	N/R	59	$15,001
2018	27	159	$20,215
2019	11	102	$12,379
2020	N/R	161	$17,171
2021	N/R	88	$7,740
2022	N/R	108	$13,883
2023	N/R	94	$11,923
2024	N/R	75	$6,970

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	209	482	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	185	266	$59
80053	Blood test, comprehensive group of blood chemicals	339	1,223	$10
36415	Insertion of needle into vein for collection of blood sample	340	1,310	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	328	1,215	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	35	980	$572,573
Revlimid	Lenalidomide	23	644	$391,442
Brukinsa	Zanubrutinib	24	720	$343,045
Erleada	Apalutamide	14	420	$190,969
Eliquis	Apixaban	62	2,100	$41,357

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	17	$3,791
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	25	$2,124
J8521	Capecitabine, oral, 500 mg	N	N/R	19	$811
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$245

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$409	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bijal J. Modi, M.D.?

Tedicare shows public-source Medicare data for Bijal J. Modi, M.D. (NPI 1285684944), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bijal J. Modi, M.D. have ACO affiliation data?

Bijal J. Modi, M.D. is shown with ACO affiliation data for UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Bijal J. Modi, M.D.?

Bijal J. Modi, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1003083445) in the available physician profile data.

Does Bijal J. Modi, M.D. have Open Payments data?

Bijal J. Modi, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.